When is the next Depo-Provera (medroxyprogesterone) shot due if the last injection was given on August 1, 2025?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Schedule the Next Depo-Provera Injection

The next Depo-Provera shot is due on October 24,2025, which is 12 weeks (84 days) after the August 1,2025 injection. 1

Timing Guidelines for Depo-Provera Administration

  • Depot medroxyprogesterone acetate (DMPA, Depo-Provera) injections should be administered every 13 weeks (91 days), with a recommended schedule of every 12 weeks (84 days) to provide a buffer period 1
  • The recommended dose is 150 mg administered intramuscularly or 104 mg administered subcutaneously 1
  • While the injection is effective for up to 15 weeks, scheduling at 12 weeks (84 days) allows for a safety margin in case the patient is delayed in getting their next injection 1

Calculation for Next Injection

  • Starting from August 1,2025:
    • Add 12 weeks (84 days) to determine the optimal return date 1
    • This calculation gives October 24,2025 as the target date for the next injection 1

Clinical Considerations

  • It is critical to ensure timely administration of repeat injections to maintain contraceptive efficacy 2
  • The failure rate of DMPA with perfect use is approximately 0.2%, but rises to about 6% with typical use, primarily due to missed or delayed injections 1
  • If a patient is more than 15 weeks from their last injection, pregnancy should be ruled out before administering the next dose 1

Pharmacokinetic Considerations

  • After injection, DMPA is detectable in serum within 30 minutes 3
  • Serum concentrations plateau at approximately 1.0 ng/mL for about three months 3
  • Contraceptive efficacy is maintained when MPA levels remain above 0.1 ng/mL (the threshold at which ovulation can resume) 3
  • While MPA can be detected in some women for up to 9 months after a single injection, scheduling regular 12-week intervals ensures continuous contraceptive coverage 3

Patient Education Points

  • Emphasize the importance of returning for the next injection on or before October 24,2025 4
  • Explain that while there is a 2-week grace period (up to 15 weeks total), the recommended interval is 12 weeks to ensure continuous contraceptive protection 1
  • Remind the patient that if they are more than 15 weeks late, a pregnancy test will be required before administering the next injection 4

Common Pitfalls to Avoid

  • Waiting too long between injections (beyond 15 weeks) significantly increases pregnancy risk 2
  • Failing to document the exact date of the previous injection can lead to timing errors 4
  • Not accounting for the patient's schedule when setting the next appointment date may lead to missed appointments 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

3-month contraceptive injection approved.

FDA medical bulletin : important information for health professionals from the U.S. Food & Drug Administration, 1993

Research

Pharmacokinetics of depot medroxyprogesterone acetate contraception.

The Journal of reproductive medicine, 1996

Research

Depo Provera. Position paper on clinical use, effectiveness and side effects.

The British journal of family planning, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.